Enalaprilat dihydrate (S)-1-((S)-2-(((S)-1-羧基-3-苯基丙基)氨基)丙酰基)吡咯烷-2-甲酸二水合物
CAS 84680-54-6 MFCD00865786
化学结构图
SMILES: C[C@H](N[C@@H](CCC1C=CC=CC=1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O
化学属性
| Mol. Formula | C18H28N2O7 |
|---|---|
| Mol. Weight | 384.42 |
| TSCA | No |
| Melting Point | 148-151° |
别名和识别编码
| Chemical Name | Enalaprilat dihydrate |
|---|---|
| MDL Number | MFCD00865786 |
| Synonym | Enalaprilic acid |
| EC Number | 278-459-3 |
| CAS Number | 76420-72-9 |
| Merck Number | 14,3568 |
| Chemical Name Translation | (S)-1-((S)-2-(((S)-1-羧基-3-苯基丙基)氨基)丙酰基)吡咯烷-2-甲酸二水合物 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. van Eickels, M., H. Vetter, and C. Grohe, Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-I (IGF-I) induced cardiac fibroblast proliferation. Br J Pharmacol, 2000. 131(8): p. 1592-6.
- [3]. Schumacher, J., et al., Effects of candesartan and enalaprilat on the organ-specific microvascular permeability during haemorrhagic shock in rats. Br J Anaesth, 2006. 96(4): p. 437-43.
- [1]. Ceconi, C., et al., Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. Eur J Pharmacol, 2007. 577(1-3): p. 1-6.
- [1]. Ceconi, C., et al., Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. Eur J Pharmacol, 2007. 577(1-3): p. 1-6.
- [2]. van Eickels, M., H. Vetter, and C. Grohe, Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-I (IGF-I) induced cardiac fi
